Pura Ballester

Dr. Pura Ballester

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Pura BallesterPura Ballester
Pura Ballester
Begoña CerdáBegoña Cerdá
Begoña Cerdá
RARaúl Arcusa
Raúl Arcusa
Javier MarhuendaJavier Marhuenda
Javier Marhuenda
KYKaren Yamedjeu
Karen Yamedjeu
Pilar ZafrillaPilar Zafrilla
Pilar Zafrilla
Ulcerative colitis, Crohn’s disease, rheumatoid arthritis, psoriasis, and lupus erythematosus are some of common inflammatory diseases. These affections are highly disabling and share signals such as inflammatory sequences and immune dysregulation. The use of foods with anti-inflammatory properties such as ginger (Zingiber officinale Roscoe) could improve the quality of life of these patients. Ginger is a plant widely used and known by its bioactive compounds. There is enough evidence to prove that ginger possesses multiple biological activities, especially antioxidant and anti-inflammatory capacities. In this review, we summarize the current knowledge about the bioactive compounds of ginger and their role in the inflammatory process and its signaling pathways. We can conclude that the compounds 6-shoagol, zingerone, and 8-shoagol display promising results in human and animal models, reducing some of the main symptoms of some inflammatory diseases such as arthritis. For lupus, 6-gingerol demonstrated a protective attenuating neutrophil extracellular trap release in response to phosphodiesterase inhibition. Ginger decreases NF-kβ in psoriasis, and its short-term administration may be an alternative coadjuvant treatment. Ginger may exert a function of supplementation and protection against cancer. Furthermore, when receiving chemotherapy, ginger may reduce some symptoms of treatment (e.g., nausea).

11 May 2023 in Molecules
Verified
Journal Article
Open access
PDF file
Pura BallesterPura Ballester
Pura Ballester
Begoña CerdáBegoña Cerdá
Begoña Cerdá
RARaúl Arcusa
Raúl Arcusa
Ana María García-MuñozAna María García-Muñoz
Ana María García-Muñoz
Javier MarhuendaJavier Marhuenda
Javier Marhuenda
Pilar ZafrillaPilar Zafrilla
Pilar Zafrilla
An increase in life expectancy leads to a greater impact of chronic non-communicable diseases. This is even more remarkable in elder populations, to whom these become main determinants of health status, affecting mental and physical health, quality of life, and autonomy. Disease appearance is closely related to the levels of cellular oxidation, pointing out the importance of including foods in one’s diet that can prevent oxidative stress. Previous studies and clinical data suggest that some plant-based products can slow and reduce the cellular degradation associated with aging and age-related diseases. Many plants from one family present several applications that range from the food to the pharmaceutical industry due to their characteristic flavor and scents. The Zingiberaceae family, which includes cardamom, turmeric, and ginger, has bioactive compounds with antioxidant activities. They also have anti-inflammatory, antimicrobial, anticancer, and antiemetic activities and properties that help prevent cardiovascular and neurodegenerative diseases. These products are abundant sources of chemical substances, such as alkaloids, carbohydrates, proteins, phenolic acids, flavonoids, and diarylheptanoids. The main bioactive compounds found in this family (cardamom, turmeric, and ginger) are 1,8-cineole, α-terpinyl acetate, β-turmerone, and α-zingiberene. The present review gathers evidence surrounding the effects of dietary intake of extracts of the Zingiberaceae family and their underlying mechanisms of action. These extracts could be an adjuvant treatment for oxidative-stress-related pathologies. However, the bioavailability of these compounds needs to be optimized, and further research is needed to determine appropriate concentrations and their antioxidant effects in the body.

26 September 2024 in Molecules
Verified
Journal Article
Open access
PDF file
Ana María García-MuñozAna María García-Muñoz
Ana María García-Muñoz
Desirée Victoria-MontesinosDesirée Victoria-Montesinos
Desirée Victoria-Montesinos
Pura BallesterPura Ballester
Pura Ballester
Begoña CerdáBegoña Cerdá
Begoña Cerdá
Pilar ZafrillaPilar Zafrilla
Pilar Zafrilla
Oxidative stress is a key factor in the development of chronic diseases such as type 2 diabetes, cardiovascular diseases, and liver disorders. Antioxidant therapies that target oxidative damage show significant promise in preventing and treating these conditions. Berberine, an alkaloid derived from various plants in the Berberidaceae family, enhances cellular defenses against oxidative stress through several mechanisms. It activates the AMP-activated protein kinase (AMPK) pathway, which reduces mitochondrial reactive oxygen species (ROS) production and improves energy metabolism. Furthermore, it boosts the activity of key antioxidant enzymes like superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), thus protecting cells from oxidative damage. These actions make berberine effective in managing diseases like type 2 diabetes, cardiovascular conditions, and neurodegenerative disorders. Silymarin, a flavonolignan complex derived from Silybum marianum, is particularly effective for liver protection. It activates the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, enhancing antioxidant enzyme expression and stabilizing mitochondrial membranes. Additionally, silymarin reduces the formation of ROS by chelating metal ions, and it also diminishes inflammation. This makes it beneficial for conditions like non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver disorders. This review aims to highlight the distinct mechanisms by which berberine and silymarin exert their antioxidant effects.

1 October 2018 in Autism Research
Verified
Journal Article
Open access
PDF file
Pura BallesterPura Ballester
Pura Ballester
MMMaría José Martínez
María José Martínez
AJAuxiliadora Javaloyes
Auxiliadora Javaloyes
MIMaría‐Del‐Mar Inda
María‐Del‐Mar Inda
NFNoemí Fernández
Noemí Fernández
APAna Peiró
Ana Peiró
Sleep problems (SP) are recognized as a common comorbid condition in autism spectrum disorder (ASD) and can influence core autism symptoms and mental and physical health. SPs can be lifelong and have been reported that adults on the autistic spectrum with and without intellectual disability (ID) present SPs (longer sleep latency, frequent night awakenings, and circadian rhythm sleep–wake disorders).A prospective, objective sleep study was conducted in 41 adults with ASD (33 ± 6 years old) and ID and 51 typically developing adults (33 ± 5 years old) using ambulatory circadian monitoring (ACM) recording wrist temperature, motor activity, body position, sleep, and light intensity. The findings indicated that individuals with ASD presented sleep difficulties including low sleep efficiency, prolonged sleep latency and increased number and length of night awakenings, together with daily sedentary behavior, and increased nocturnal activity. Furthermore, indications of an advanced sleep–wake phase disorder were found in these autistic adults. Examining sleep and markers of the circadian system showed significant differences between adults with ASD and ID and an age‐matched, healthy adult population. The sleep disturbances described for this sample of adults with ASD and ID are similar to those of already described for adults with ASD without ID; their relationship with intellectual ability should be further studied. Improving knowledge of sleep patterns in ASD adults with ID might help to designed targeted interventions to improve their functioning and reduce family stress.Autism Research2019, 12: 66–79. © 2018 International Society for Autism Research, Wiley Periodicals, Inc.Lay Summary: SPs are very frequent in autism from childhood to adulthood. We recorded sleep with a watch‐like device in adults with autism and ID and compared sleep patterns with nonautistic volunteers. Results showed poorer sleep conditions in adults with autism (increased sleep latency and number/length of night awakenings) that resulted in decreased sleep efficiency. Increasing knowledge of the SPs in adults on the autism spectrum will allow to improve their and their families' quality of life.

1 December 2020 in Sleep Medicine Reviews
Verified
Journal Article
Closed access
Pura BallesterPura Ballester
Pura Ballester
ARA.L. Richdale
A.L. Richdale
EBE.K. Baker
E.K. Baker
APA.M. Peiró
A.M. Peiró

20 November 2019 in The Pharmacogenomics Journal
Verified
Journal Article
Closed access
PDF file
BPBeatriz Planelles
Beatriz Planelles
CMCésar Margarit
César Margarit
MIMaría-Del-Mar Inda
María-Del-Mar Inda
Pura BallesterPura Ballester
Pura Ballester
JMJavier Muriel
Javier Muriel
APAna Peiró
Ana Peiró